Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Ghouzlani A"'
Autor:
Abdou-samad Kone, Amina Ghouzlani, Ahmed Qandouci, Nour el Imane Issam Salah, Yann Bakoukou, Abdelhakim Lakhdar, Mehdi Karkouri, Abdallah Badou
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionGliomas represent the most prevalent and aggressive tumors within the central nervous system. Despite the current standard treatments, the median survival time for glioblastoma patients remains dismal, hovering around 14 months. While att
Externí odkaz:
https://doaj.org/article/b3ba4b6f94664490ac05a6c8b6dff319
Autor:
Jasper Iske, Rachid El Fatimy, Yeqi Nian, Amina Ghouzlani, Siawosh K Eskandari, Hector Rodriguez Cetina Biefer, Anju Vasudevan, Abdallah Elkhal
Publikováno v:
eLife, Vol 12 (2024)
Septic shock is characterized by an excessive inflammatory response depicted in a cytokine storm that results from invasive bacterial, fungi, protozoa, and viral infections. Non-canonical inflammasome activation is crucial in the development of septi
Externí odkaz:
https://doaj.org/article/6410250cdc9641cd81f3ab1c6b6fde32
Autor:
Hayat Miftah, Oumayma Naji, Saadia Ait Ssi, Amina Ghouzlani, Abdelhakim Lakhdar, Abdallah Badou
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntoroductionNuclear receptor subfamily 2 group F member 6 (NR2F6) is a promising checkpoint target for cancer immunotherapy. However, there has been no investigation of NR2F6 in glioma. Our study systematically explored the clinical characteristics
Externí odkaz:
https://doaj.org/article/7b97c89d1806466fa54081f97955ea3a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Soumaya Rafii, Sarah Kandoussi, Amina Ghouzlani, Oumayma Naji, Konala Priyanka Reddy, Rizwan Ullah Sadiqi, Abdallah Badou
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Gliomas are considered one of the most malignant cancers in the body. Despite current therapies, including surgery, chemotherapy, and radiotherapy, these tumors usually recur with more aggressive and resistant phenotypes. Indeed, the survival followi
Externí odkaz:
https://doaj.org/article/46d0cc04bd174c03963c79ead3a61bca
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract In human gliomas, anti-tumor T cell responses are inhibited through induction of local and systemic immunosuppression. Immune checkpoint blockade is proving to be a success in several types of cancers. However, many studies reported that the
Externí odkaz:
https://doaj.org/article/2d63a8a9061749b18bfd3005525a1a84
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chimeric antigen receptor (CAR) T-cells represent a new genetically engineered cell-based immunotherapy tool against cancer. The use of CAR T-cells has revolutionized the therapeutic approach for hematological malignancies. Unfortunately, there is a
Externí odkaz:
https://doaj.org/article/8d93da66ad294b82b96f4d64124d863f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rafii, Soumaya1 (AUTHOR), Ghouzlani, Amina1 (AUTHOR), Naji, Oumayma1 (AUTHOR), Ait Ssi, Saadia1 (AUTHOR), Kandoussi, Sarah1 (AUTHOR), Lakhdar, Abdelhakim2 (AUTHOR), Badou, Abdallah1,3 (AUTHOR) abdallah.badou@univh2c.ma
Publikováno v:
International Journal of Molecular Sciences. Apr2023, Vol. 24 Issue 7, p6688. 19p.
Autor:
Soumaya Rafii, Amina Ghouzlani, Oumayma Naji, Saadia Ait Ssi, Sarah Kandoussi, Abdelhakim Lakhdar, Abdallah Badou
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6688 (2023)
Gliomas are considered one of the most malignant tumors in the body. The immune system has the ability to control the initiation and development of tumors, including gliomas. Thus, immune cells find themselves controlled by various molecular pathways
Externí odkaz:
https://doaj.org/article/5001f4b2c5b34e90b87969ce43fe8ad5